News and Announcements
Bioactive Annual Update 2016; New Compounds & Fractions Discovered, New Substance Pre-Screening Passed & Commercial Relationships Formed
- Published January 31, 2017 3:25PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Platform technology experts, Bioactive, continues to move forward with their capital raise along with achieving set targets during 2016:
- ‘Bioactive Therapeutics’, the Drug Discovery Division, has discovered new compounds and fractions to firmly establish a compound library within the key streams of inflammatory disorders and infectious diseases.
- ‘Bioactive Natural Health’, the Listed Medicine Division, has passed a rigorous TGA new substance pre-screening to proceed to full evaluation. Commercial relationships have been formed with some of the region’s largest companies and expect to be formalised to coincide with TGA approval in 2017.
- These opportunities collectively service the global market of 7 billion people. An investor exit is planned within 2 years.